Objective: To observe the clinical curative effect of Fuming capsule in the treatment of liver and kidney yin deficiency of dry from agerelated macular degeneration(AMD). Method: Sixty-four patients of dry AMD were randomly allocated into control group and experimental group

32 patients (64 eyes)in each group. In the control group

Mingmu Dihuang pills

8 to 10 pills/time

3 times/d

were oral administrated while in the experimental group

fuming capsule

5 capsules/time

3 times/d

oral taken. Both groups were treated for 12 weeks. The visual acuity

central visual field

retinal drusen area

the liver and kidney yin deficiency syndrome and life quality before and after the treatment were measured. Result: The total effectiveness of experimental group was 71.87%

better than that of the control group with 51.56% (P<0.01);the improvement of visual acuity and central scotoma distribution in the experimental group was better than that in the control group (P<0.05); drusen area of the experimental group was smaller than that of the control group (P<0.01) after treatment; scores to measure the symptoms of blurred vision

metamorphopsia

dry eyes along with liver and kidney yin deficiency syndrome scales of the experimental group were lower than the control group (P<0.01);the living quality of the experimental group was better than that of the control group (P<0.01). Conclusion: Fuming capsule can improve the clinical symptoms

eyesight

vision and life quality of liver and kidney yin deficiency of dry AMD

its curative effect is obvious so that it is worthy of clinical use.